Company Data

Immunome Inc.

Ticker
IMNM
Current Price
$9.51 -3.94%
Market Cap
$827.8M
Price Target
Refer to Report
Volume
684.1K
52wk Range
$5.1501 - $16.73
Advanced Market Data

Overview

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The company’s primary focus areas are oncology and infectious disease, including COVID-19.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy